Molecular Testing May Be Underused, Delaying Therapy in Metastatic NSCLC
Cancer Therapy Advisor,
Molecular testing may be underused in patients with metastatic non-small cell lung cancer (NSCLC), according to a study…
Factors Associated With Receipt of Molecular Testing and its Impact on Time to Initial Systemic Therapy in Metastatic Non-Small Cell Lung Cancer
Overview of attention for article published in Clinical Lung Cancer, March 2023
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (86th percentile)
-
Good Attention Score compared to outputs of the same age and source (70th percentile)
Readers on
- mendeley
- 10 Mendeley